Author:
Mourgues Cindy,Henquell Cécile,Tatar Zuzana,Pereira Bruno,Nourisson Cynthia,Tournadre Anne,Soubrier Martin,Couderc Marion
Reference32 articles.
1. Interleukin 6 and rheumatoid arthritis;Yoshida;Biomed Res Int,2014
2. Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease;Maini;Immunol Rev,1995
3. Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation;Malottki;Health Technol Assess,2011
4. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial;Nishimoto;Arthritis Rheumatism,2004
5. Tocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK;Diamantopoulos;Pharmacoeconomics,2014